Home
About
Overview
Sharing Data
ORCID
Help
History (51)
Safety and activity of IT-139, a ruthenium-based compound, in patients with advanced solid tumours: a first-in-human, open-label, dose-escalation phase I study with expansion cohort.
Screening for prenatal substance use: development of the Substance Use Risk Profile-Pregnancy scale.
Generation of monoclonal antibodies against soluble human T cell receptor polypeptides.
Triticale
Biophysical targeting of high-risk cerebral aneurysms.
See All 51 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Biophysical targeting of high-risk cerebral aneurysms.
Epshtein M, Levi M, Kraitem AM, Zidan H, King RM, Gawaz M, Gounis MJ, Korin N. Biophysical targeting of high-risk cerebral aneurysms. Bioeng Transl Med. 2022 Jan; 7(1):e10251.
View in:
PubMed
authors with profiles
Matthew J Gounis PhD
Robert Michael King PhD